Publications by authors named "Mathieu Verbeken"

Claim this Profile
B
Blood-brain transfer and antinociception of linear and cyclic N-methyl-guanidine and thiourea-enkephalins.
Mathieu Verbeken, Evelien Wynendaele, Elodie Mauchauffée, Nathalie Bracke, Sofie Stalmans

Peptides· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of peptide impurity profiles on functional tissue-organ bath response: the 11-mer peptide INSL6[151-161] case.
Mathieu Verbeken, Evelien Wynendaele, Romain A Lefebvre, Els Goossens, Bart De Spiegeleer

Anal Biochem· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stability-indicating HPLC-DAD/UV-ESI/MS impurity profiling of the anti-malarial drug lumefantrine.
Mathieu Verbeken, Sultan Suleman, Bram Baert, Elien Vangheluwe, Sylvia Van Dorpe

Malar J· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of peptide receptor binding assays: methods to avoid false negatives.
Valentijn Vergote, Sylvia Van Dorpe, Mathieu Verbeken, Christian Burvenich, Christophe Van de Wiele

Regul Pept· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrathecally injected Ile-Pro-Ile, an inhibitor of membrane ectoenzyme dipeptidyl peptidase IV, is antihyperalgesic in rats by switching the enzyme from hydrolase to synthase functional mode to generate endomorphin 2.
Kornél Király, Balázs Szalay, Judit Szalai, István Barna, Klára Gyires, Mathieu Verbeken

Eur J Pharmacol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis